(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione

C36H41F6N7O5 — CID 90878666

IUPAC(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione
SMILESCCc1c(NC[C@H](CC(=O)N[C@@H](C)c2ccccc2)C(=O)O)ncnc1N1CCC(c2ccc3c(n2)NCCC3)CC1.O=C(C(=O)C(F)(F)F)C(F)(F)F
InChIInChI=1S/C32H41N7O3.C4F6O2/c1-3-26-30(34-19-25(32(41)42)18-28(40)37-21(2)22-8-5-4-6-9-22)35-20-36-31(26)39-16-13-23(14-17-39)27-12-11-24-10-7-15-33-29(24)38-27;5-3(6,7)1(11)2(12)4(8,9)10/h4-6,8-9,11-12,20-21,23,25H,3,7,10,13-19H2,1-2H3,(H,33,38)(H,37,40)(H,41,42)(H,34,35,36);/t21-,25-;/m0./s1
InChIKeyYPNPBTOZWNXEGQ-OWEKSZQWSA-N
MW765.76 g/mol
LogP5.81
Rot. Bonds12

About (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione

(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione (PubChem CID 90878666) has the molecular formula C36H41F6N7O5 and a molecular weight of 765.76 g/mol. Its IUPAC name is (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione.

Molecular Properties

Compound Name(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione
PubChem CID90878666
Molecular FormulaC36H41F6N7O5
Molecular Weight765.76 g/mol
Exact Mass765.31
IUPAC Name(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione
SMILESCCc1c(NC[C@H](CC(=O)N[C@@H](C)c2ccccc2)C(=O)O)ncnc1N1CCC(c2ccc3c(n2)NCCC3)CC1.O=C(C(=O)C(F)(F)F)C(F)(F)F
InChIInChI=1S/C32H41N7O3.C4F6O2/c1-3-26-30(34-19-25(32(41)42)18-28(40)37-21(2)22-8-5-4-6-9-22)35-20-36-31(26)39-16-13-23(14-17-39)27-12-11-24-10-7-15-33-29(24)38-27;5-3(6,7)1(11)2(12)4(8,9)10/h4-6,8-9,11-12,20-21,23,25H,3,7,10,13-19H2,1-2H3,(H,33,38)(H,37,40)(H,41,42)(H,34,35,36);/t21-,25-;/m0./s1
InChIKeyYPNPBTOZWNXEGQ-OWEKSZQWSA-N
XLogP5.81
TPSA166.51 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds12
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500765.76
LogP ≤ 55.81
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
The IUPAC name of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione (CID 90878666) is (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione.
What is the SMILES notation for (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
The canonical SMILES for (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione is CCc1c(NC[C@H](CC(=O)N[C@@H](C)c2ccccc2)C(=O)O)ncnc1N1CCC(c2ccc3c(n2)NCCC3)CC1.O=C(C(=O)C(F)(F)F)C(F)(F)F.
What is the InChIKey of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
The InChIKey is YPNPBTOZWNXEGQ-OWEKSZQWSA-N. The full InChI is InChI=1S/C32H41N7O3.C4F6O2/c1-3-26-30(34-19-25(32(41)42)18-28(40)37-21(2)22-8-5-4-6-9-22)35-20-36-31(26)39-16-13-23(14-17-39)27-12-11-24-10-7-15-33-29(24)38-27;5-3(6,7)1(11)2(12)4(8,9)10/h4-6,8-9,11-12,20-21,23,25H,3,7,10,13-19H2,1-2H3,(H,33,38)(H,37,40)(H,41,42)(H,34,35,36);/t21-,25-;/m0./s1.
What are the key properties of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione has a molecular weight of 765.76 g/mol, XLogP of 5.81, 12 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione is sourced from PubChem (CID 90878666), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).